Consonance Capital Management LP Aerie Pharmaceuticals Inc Transaction History

Consonance Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $27.7 Million - $42.2 Million	-1,506,695 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $5.51 Million - $9.16 Million	-190,078 Reduced 11.2%	1,506,695 $44.5 Million
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $61.6 Million - $83.6 Million	1,696,773 New	1,696,773 $80.6 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.